Vaccine Manufacture Facilities

JN's one of the fastest growing biomedical company invested US$ 25 million manufacture and research facility, which has two dedicated buildings for bacterial and neurological disease vaccines production. it has hi-tech production lines for vaccines with a media preparation capacity in fermentors ranging from 30 to 1000 liters. The availability of state-of-the-art fermentors and clean rooms, in combination with efficient, integrated up-/downstream processing operations and automation makes the new unit a landmark in meningococcal bacterial vaccine or neurological vaccine manufacturing in the United States of America.